Retatrutide activates three hormone receptors (GIP, GLP-1, and glucagon) instead of one (semaglutide: GLP-1 only) or two (tirzepatide: GLP-1 + GIP)
Because the FDA has signaled a tightening direction for compounded semaglutide and tirzepatide, a well-run platform should be able to explain how it would handle further restrictions, whether through 503A patient-specific compounding, a transition to brand-name options, or another route
Our products are NON-GMO, clinically studied, FSSAI approved, and made in WHO GMP certified facility
We further found that the melatonin receptor 1B (MTNR1B), rather than melatonin receptor 1 A (MTNR1A), is essential for MT mediated TRIP13 downregulation
"The effect of glycine administration on the characteristics of physiological systems in human adults: A systematic review." Geroscience
There is no single best injection for weight loss